Pfizer CEO on Drug Pipeline, Trump's Pick to Lead CDC
Pfizer Inc. Chief Executive Officer Albert Bourla says President Donald Trump's nominee to lead the Centers for Disease Control and Prevention is a good choice.
Bourla says Erica Schwartz is a “very credible scientist." Bourla also talks about earnings, their drug pipeline and doing business in China.
He speaks to Bloomberg's David Westin. (Source: Bloomberg)
Pfizer beats Q1 earnings estimates
- Pfizer's newer drugs pushed earnings past Wall Street expectations Quartz —
- Pfizer Posts Better-Than-Expected Revenue, Profit Wall Street Journal —
- Pfizer Revenue Rises But Profit Falls Amid Boosted R&D Spending Wall Street Journal —
- Pfizer tops Wall Street estimates, reaffirms outlook as newer products show growth CNBC —
- Earnings Snapshot: Pfizer beats Q1 estimates but misses guidance Seeking Alpha —